Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lash, T. L.
Right arrow Articles by Silliman, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lash, T. L.
Right arrow Articles by Silliman, R. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Am J Epidemiol 2003; 157:249-257.
Copyright © 2003 by Johns Hopkins Bloomberg School of Public Health


PRACTICE OF EPIDEMIOLOGY

Multiple Informants: A New Method to Assess Breast Cancer Patients’ Comorbidity

Timothy L. Lash1,2,, Soe Soe Thwin3, Nicholas J. Horton3,4, Edward Guadagnoli5 and Rebecca A. Silliman1,2

1 Department of Epidemiology, Boston University School of Public Health, Boston, MA.
2 Geriatrics Section, Department of Medicine, Boston University School of Medicine, Boston, MA.
3 Department of Biostatistics, Boston University School of Public Health, Boston, MA.
4 General Internal Medicine Section, Department of Medicine, Boston University School of Medicine, Boston, MA.
5 Department of Health Care Policy, Harvard Medical School, Boston, MA.

Past assessments of comorbidity indices have sought to recommend a single index that performs better than others. The authors used a multiple informants approach as an alternative method to simultaneously assess five indices of comorbidity. This approach provides a single estimate of the overall effect of comorbidity and evaluates the relation any individual index has to the outcomes of interest. Association of comorbidity with definitive primary therapy, discussion of tamoxifen, and receipt of tamoxifen was evaluated in a cohort of 830 older breast cancer patients enrolled at four geographically distinct centers in the United States from 1996 to 1999. The estimated adjusted effect of a unit increase in comorbidity on the odds of discussing tamoxifen therapy was 0.70 (95% confidence interval: 0.56, 0.88). An increase in comorbidity was not associated with receipt of definitive primary therapy (odds ratio = 0.94, 95% confidence interval: 0.79, 1.13) or receipt of tamoxifen (odds ratio = 0.96, 95% confidence interval: 0.72, 1.27). The multiple informants regression proved superior to separate regression models that included only one index. In analyses that require comorbidity adjustment and for which no single index is expected to be ideal, the multiple informants approach is an attractive alternative to selecting a single index and to other methods of using multiple indices.

breast neoplasms; comorbidity; epidemiologic factors; epidemiologic methods

Abbreviations: Abbreviations: ASA, American Society of Anesthesiologists; ICED, Index of Coexistent Diseases.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
S.-L. T. Normand
Some Old and Some New Statistical Tools for Outcomes Research
Circulation, August 19, 2008; 118(8): 872 - 884.
[Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
T. L. Lash, V. Mor, D. Wieland, L. Ferrucci, W. Satariano, and R. A. Silliman
Methodology, Design, and Analytic Techniques to Address Measurement of Comorbid Disease
J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2007; 62(3): 281 - 285.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
M L G Janssen-Heijnen, S Smulders, V E P P Lemmens, F W J M Smeenk, H J A A van Geffen, and J W W Coebergh
Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer
Thorax, July 1, 2004; 59(7): 602 - 607.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.